Habsheim, France

Valérie Verhoeven


Average Co-Inventor Count = 3.7

ph-index = 1


Company Filing History:


Years Active: 2019-2020

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Valérie Verhoeven: Innovator in Pharmaceutical Formulations

Introduction

Valérie Verhoeven is a notable inventor based in Habsheim, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative formulations. With a total of 2 patents to his name, Verhoeven's work is recognized for its potential impact on medical treatments.

Latest Patents

One of Verhoeven's latest patents is a pharmaceutical formulation comprising sembragiline. This invention relates to a film-coating tablet that includes sembragiline or a salt thereof. Another significant patent involves diazabicyclooctane compounds, which are described in terms of their chemical structure and potential applications. These compounds are useful as antibacterial agents and β-lactamase inhibitors, which can aid in the treatment of infectious diseases.

Career Highlights

Valérie Verhoeven is currently associated with Hoffmann-La Roche Inc., a leading company in the pharmaceutical industry. His work focuses on developing formulations that can enhance the efficacy of treatments for various health conditions. Verhoeven's innovative approach has positioned him as a key player in pharmaceutical research and development.

Collaborations

Throughout his career, Verhoeven has collaborated with esteemed colleagues, including Zoltan Mathe and Lene Maurer. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in pharmaceutical science.

Conclusion

Valérie Verhoeven's contributions to pharmaceutical formulations demonstrate his commitment to innovation in the medical field. His patents reflect a dedication to improving treatment options for infectious diseases. Verhoeven's work continues to inspire advancements in pharmaceutical research and development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…